Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Red Light Holland has highlighted the publication of a pivotal randomized clinical trial revealing that a single administration of psilocybin can reduce cocaine use. Filament Health holds the exclusive license to the trial's data and intellectual property, positioning the company at the forefront of psychedelic-assist…
Share This Article
Ready-to-post copy includes the article link.
Red Light Holland Spotlights Clinical Trial Confirming Psilocybin's Efficacy in Reducing Cocaine Use, with Filament Health Holding Exclusive IP License Red Light Holland has highlighted the publication of a pivotal randomized clinical trial revealing that a single administration of psilocybin can reduce cocaine use. Filament Health holds the exclusive license to the tr... Read the full IIPLA article: https://iipla.org/news/red-light-holland-spotlights-clinical-trial-confirming-psilocybin-s-efficacy-in-reducing-cocaine-use-with-filament-health-holding-exclusive-ip-license